Ivabradine in acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials [0.03%]
急性心肌梗死患者使用伊伐布雷定的系统评价和meta分析研究
Chia Siang Kow,Abdullah Faiz Zaihan,Syed Shahzad Hasan et al.
Chia Siang Kow et al.
Introduction: While effective in stable angina and chronic heart failure, ivabradine's role in acute myocardial infarction (AMI) is less clear. We assessed the effects of ivabradine versus placebo or standard care on all-...
Management of acute cardiovascular consequences of sleep disorders: clinical implications for improved patient outcomes [0.03%]
睡眠障碍的急性心血管后果的管理：改善患者预后的临床意义
Ritu Prakash Chandra Tated,Darshilkumar Maheta,Saptak Mankad et al.
Ritu Prakash Chandra Tated et al.
Introduction: Sleep disorders such as insomnia, restless legs syndrome (RLS) and sleep disordered breathing such as obstructive sleep apnea (OSA) and central sleep apnea (CSA) are increasingly recognized as independent ri...
Management of new-onset postoperative atrial fibrillation after coronary artery bypass grafting [0.03%]
冠状动脉旁路移植术后新发房颤的管理
Florian E M Herrmann,Anders Jeppsson,Amar Taha
Florian E M Herrmann
Introduction: New-onset postoperative atrial fibrillation (POAF) is the most common arrhythmia after coronary artery bypass grafting (CABG). Traditionally regarded as a benign and self-limiting event, more recent evidence...
Can vascular biomarkers be used in hypertension management to improve cardiovascular outcomes? [0.03%]
血管生物标志物能否用于高血压管理以改善心血管结局？
Tomoyuki Kabutoya
Tomoyuki Kabutoya
Introduction: The association between vascular biomarkers as indices of atherosclerosis and cardiovascular events has been widely reported. Measurement of vascular biomarkers has been used for risk stratification and prog...
How coronary plaque morphology affects fractional flow reserve: clinical evidence from intravascular imaging studies [0.03%]
冠状动脉斑块形态如何影响血流储备分数：来自血管内影像学研究的临床证据
Kota Murai,Yu Kataoka,Satoshi Honda et al.
Kota Murai et al.
Introduction: Fractional flow reserve (FFR) is widely used to assess the functional significance of coronary artery disease (CAD). However, the severity of anatomical stenosis does not always correspond with the extent of...
Prioritizing surgical ablation for atrial fibrillation during coronary artery bypass grafting: new evidence, old debate [0.03%]
冠脉搭桥术中优先进行房颤外科消融手术：新的证据，老的争论
Ely Erez,John J Squiers,Cody W Dorton et al.
Ely Erez et al.
Introduction: Atrial fibrillation (AF) affects 10-20% of patients undergoing coronary artery bypass grafting (CABG) and is associated with increased postoperative morbidity and mortality. Although studies support the safe...
Secretoneurin as a novel cardiovascular biomarker and potential therapeutic strategy [0.03%]
分泌神经肽作为新型心血管生物标志物和潜在治疗策略的研究
Anett H Ottesen,Helge Røsjø,Torbjørn Omland
Anett H Ottesen
Introduction: Secretoneurin (SN) is a prognostic biomarker in cardiovascular disease (CVD), and circulating SN concentrations have been associated with clinical outcomes in various cohort of CVDs. SN reflects other cellul...
How can we best utilize atherosclerotic burden as a predictor of vascular outcomes in atrial fibrillation patients? [0.03%]
动脉粥样硬化负担在房颤患者血管预后预测中的作用及利用方式探讨
Nicola Mumoli,Stefania Marengo,Francesco Cei
Nicola Mumoli
Evaluating catheter usage for atrial fibrillation ablation: improving rates of efficacy and safety [0.03%]
评估心房颤动消融导管使用情况：提高有效性和安全性的方法
Sara Poggi,Assunta Iuliano,Giorgio Spiniello et al.
Sara Poggi et al.
Introduction: Pulmonary vein (PV) isolation remains the cornerstone of atrial fibrillation (AF) catheter ablation. While the single-tip radiofrequency based PV isolation in conjunction with a 3-D mapping system was for ma...
Coronary artery bypass grafting versus percutaneous coronary intervention outcomes among patients with acute coronary syndrome and unprotected left main coronary artery disease: a meta-analysis with a reconstructed time-to-event analysis [0.03%]
急性冠脉综合征合并左主干病变患者行冠状动脉旁路移植术与经皮冠状动脉介入治疗预后的meta分析及基于重建的生存分析
Mohammed A Elbahloul,Ahmed Farid Gadelmawla,Ahmed Hamdy G Ali et al.
Mohammed A Elbahloul et al.
Introduction: Patients with an unprotected left main coronary artery (ULMCA) presenting with acute coronary syndrome (ACS) were underrepresented in randomized trials. We aimed to compare the outcomes of coronary artery by...